Safety Evaluation of an Advanced Hybrid Closed Loop System Using Lyumjev With the Tandem t:Slim X2 Insulin Pump With Control-IQ Technology in Adults, Adolescents and Children With Type 1 Diabetes
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
13 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Children'S Hospital Orange County
Orange, California, United States
- Stanford University
Palo Alto, California, United States
- Barbara Davis Center
Aurora, Colorado, United States
- University of Florida
Gainesville, Florida, United States
- University of South Florida Diabetes Center
Tampa, Florida, United States
- Northwestern University
Evanston, Illinois, United States
- Indiana University / Riley Hospital for Children
Indianapolis, Indiana, United States
- Iowa Diabetes and Endocrinology Research Center (iderc)
West Des Moines, Iowa, United States
- Joslin Diabetes Center
Boston, Massachusetts, United States
- Children'S Mercy Hospital
Kansas City, Missouri, United States
- Icahn School of Medicine at Mt. Sinai
New York, New York, United States
- Diabetes & Glandular Disease (dgd)
San Antonio, Texas, United States
- University of Virginia
Charlottesville, Virginia, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Aug 2022
- Primary completion
- 2 Aug 2023
- Completion
- 2 Aug 2023
- Last update posted
- 26 Jul 2024
- Registered enrollment
- 183
- Registry id
- NCT05403502
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.